PubRank

G Vecchione

Author PubWeight™ 15.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med 1998 1.20
2 The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998 1.13
3 Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997 1.11
4 The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 1998 1.02
5 PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol 1998 0.99
6 An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997 0.93
7 Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod 2004 0.88
8 Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 1997 0.87
9 Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996 0.86
10 Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 1994 0.84
11 Plasma lipoprotein(a) levels in subjects attending a metabolic ward. Discrimination between individuals with and without a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996 0.81
12 A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing. Blood 2000 0.79
13 In vitro inhibition by defibrotide of monocyte superoxide anion generation: a possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug. Haemostasis 1991 0.79
14 Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006 0.78
15 Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study. Stroke 1998 0.78
16 Fibrinogen and mechanisms of thrombosis. A difficult link. Eur J Epidemiol 1992 0.77
17 C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives. Arterioscler Thromb Vasc Biol 2000 0.77
18 [The cardiorespiratory function after bronchopneumopathies caused by irritant gases]. Poumon Coeur 1970 0.75
19 Raised plasma fibrinogen concentrations in subjects attending a metabolic ward--relation to family history and vascular risk factors. Thromb Haemost 1995 0.75
20 A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. Thromb Haemost 2001 0.75
21 Searching for the thrombogenic mechanism(s) of fibrinogen. Thromb Res Suppl 1990 0.75
22 [Impairment of diuresis in surgical intervention. Role of urinary prostaglandins]. Minerva Anestesiol 1990 0.75
23 Genetic polymorphism of 5,10-MTHFR reductase gene in offspring of patients with myocardial infarction. Thromb Haemost 1999 0.75
24 Detection of the factor V Leiden using SSCP. Thromb Haemost 1996 0.75
25 Fibrinogen plasma levels in an apparently healthy general population--relation to environmental and genetic determinants. Thromb Haemost 1998 0.75
26 Cu/Zn superoxide dismutase in patients with non-familial Alzheimer's disease. Aging (Milano) 1995 0.75